Clinical Trial Update: Genetic Determinants of Amitriptyline Efficiency for Pain Treatment - Part II [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update (Part II) evaluating genetic determinants of amitriptyline effectiveness for chronic pain; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• amitriptyline (amitriptyline)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Chronic Pain | Phase 4 | Status: COMPLETED